Rayner Intraocular Lenses Limited (Rayner), the leading intraocular lens (IOL) pioneer has introduced *RaySert®, a small-incision IOL injector system. With a 1.8-mm diameter external tip, RaySert® enables surgeons to insert an IOL through a sub-2.5-mm incision, reducing surgically induced astigmatism.
Injectable IOL BiomaterialAll Rayner injectable lenses are manufactured from Rayacryl®, Rayner’s own proprietary hydrophilic acrylic co-polymer of 2-hydroxy ethyl methacrylate (HEMA) and methyl methacrylate (MMA) with ethylene glycol dimethacrylate (EGDMA) as cross-linking agent. |
Rayacryl® hydrophilic acrylic 5% silicone oil adherence |
Acrysof® hydrophobic acrylic 35% adherence
|
The Amon-Apple Enhanced Square Edge is a unique Rayner design (patent pending) which reduces Posterior Capsular Opacification (PCO) by creating an insurmountable physical barrier to cell migration. Photo is courtesy of David J Apple MD, an SEM study of the fine surface finish on the haptic-optic junction of a Rayacryl® lens with the new edge.
Read More
Anti-Vaulting Haptic TechnologyOnly Rayner injectable IOLs incorporate AVH Technology® to give unsurpassed clinical results. |
 |
 |
 |
Rayner Intraocular Lenses Limited (Rayner), the leading intraocular lens (IOL) pioneer has introduced *RaySert®, a small-incision IOL injector system. With a 1.8-mm diameter external tip, RaySert® enables surgeons to insert an IOL through a sub-2.5-mm incision, reducing surgically induced astigmatism.
Injectable IOL BiomaterialAll Rayner injectable lenses are manufactured from Rayacryl®, Rayner’s own proprietary hydrophilic acrylic co-polymer of 2-hydroxy ethyl methacrylate (HEMA) and methyl methacrylate (MMA) with ethylene glycol dimethacrylate (EGDMA) as cross-linking agent. |
Rayacryl® hydrophilic acrylic 5% silicone oil adherence |
Acrysof® hydrophobic acrylic 35% adherence
|
Anti-Vaulting Haptic TechnologyOnly Rayner injectable IOLs incorporate AVH Technology® to give unsurpassed clinical results. |
|
|
|
The Amon-Apple Enhanced Square Edge is a unique Rayner design (patent pending) which reduces Posterior Capsular Opacification (PCO) by creating an insurmountable physical barrier to cell migration. Photo is courtesy of David J Apple MD, an SEM study of the fine surface finish on the haptic-optic junction of a Rayacryl® lens with the new edge.
|
|
|
Watch the Rayner Injector Loading Video |
|
|
|
Read more about the Rayner Aspheric IOLs |
|
|
|
Read more about the Rayacryl® IOL Material |
|
|
|
Read more about the Rayner Aspheric IOLs |
|
|
|
Read more about Silicone Oil |
|
|
|
Read more about the Enhanced Square Edge |
|
|
|
Read more about the Rayner T-flex® toric IOL |
|
|
|
Do You Suffer From Dry Eye? |
|
|
|
Souffrez-vous du syndrome de l'oeil sec? |
|
|
|
Read more about the I-Drop® |
